Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.
Zarogoulidis K, Ziogas E, Boutsikou E, Zarogoulidis P, Darwiche K, Kontakiotis T, Tsakiridis K, Porpodis K, Latsios D, Chatzizisi O, Karapantzos I, Li Q, Kyriazis G. Zarogoulidis K, et al. Among authors: zarogoulidis p. Drug Des Devel Ther. 2013 Jul 23;7:611-7. doi: 10.2147/DDDT.S43184. Print 2013. Drug Des Devel Ther. 2013. PMID: 23901264 Free PMC article. Clinical Trial.
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer.
Boutsikou E, Kontakiotis T, Zarogoulidis P, Darwiche K, Eleptheriadou E, Porpodis K, Galaktidou G, Sakkas L, Hohenforst-Schmidt W, Tsakiridis K, Karaiskos T, Zarogoulidis K. Boutsikou E, et al. Among authors: zarogoulidis p, zarogoulidis k. Onco Targets Ther. 2013;6:125-34. doi: 10.2147/OTT.S42245. Epub 2013 Mar 1. Onco Targets Ther. 2013. PMID: 23467839 Free PMC article.
New dilemmas in small-cell lung cancer TNM clinical staging.
Zarogoulidis K, Latsios D, Porpodis K, Zarogoulidis P, Darwiche K, Antoniou N, Hohenforst-Schmidt W, Eleftheriadou E, Boutsikou E, Kontakiotis T. Zarogoulidis K, et al. Among authors: zarogoulidis p. Onco Targets Ther. 2013 May 16;6:539-47. doi: 10.2147/OTT.S44201. Print 2013. Onco Targets Ther. 2013. PMID: 23700372 Free PMC article.
Clinical experimentation with aerosol antibiotics: current and future methods of administration.
Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H, Li Q, Turner JF, Browning R, Hohenforst-Schmidt W, Zarogoulidis K. Zarogoulidis P, et al. Among authors: zarogoulidis k. Drug Des Devel Ther. 2013 Oct 2;7:1115-34. doi: 10.2147/DDDT.S51303. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24115836 Free PMC article. Review.
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis.
Zarogoulidis K, Boutsikou E, Zarogoulidis P, Darwiche K, Freitag L, Porpodis K, Latsios D, Kontakiotis T, Huang H, Li Q, Hohenforst-Schmidt W, Kipourou M, Turner JF, Spyratos D. Zarogoulidis K, et al. Among authors: zarogoulidis p. Onco Targets Ther. 2013 Oct 22;6:1493-500. doi: 10.2147/OTT.S52330. eCollection 2013. Onco Targets Ther. 2013. PMID: 24174880 Free PMC article.
Inhaled chemotherapy in lung cancer: future concept of nanomedicine.
Zarogoulidis P, Chatzaki E, Porpodis K, Domvri K, Hohenforst-Schmidt W, Goldberg EP, Karamanos N, Zarogoulidis K. Zarogoulidis P, et al. Among authors: zarogoulidis k. Int J Nanomedicine. 2012;7:1551-72. doi: 10.2147/IJN.S29997. Epub 2012 Mar 22. Int J Nanomedicine. 2012. PMID: 22619512 Free PMC article. Review.
Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today.
Kallianos A, Tsimpoukis S, Zarogoulidis P, Darwiche K, Charpidou A, Tsioulis I, Trakada G, Porpodis K, Spyratos D, Panoutsopoulos A, Veletza L, Kostopoulos K, Kostopoulos C, Karapantzos I, Tsakiridis K, Hohenforst-Schmidt W, Zarogoulidis K, Rapti A, Syrigos K. Kallianos A, et al. Among authors: zarogoulidis p, zarogoulidis k. Onco Targets Ther. 2013 May 31;6:609-13. doi: 10.2147/OTT.S44087. Print 2013. Onco Targets Ther. 2013. PMID: 23807853 Free PMC article.
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.
Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, Vogl T, Goldberg EP, Huang H, Simoff M, Li Q, Browning R, Turner FJ, Le Pivert P, Spyratos D, Zarogoulidis K, Celikoglu SI, Celikoglu F, Brachmann J. Hohenforst-Schmidt W, et al. Among authors: zarogoulidis p, zarogoulidis k. Drug Des Devel Ther. 2013 Jul 18;7:571-83. doi: 10.2147/DDDT.S46393. Print 2013. Drug Des Devel Ther. 2013. PMID: 23898222 Free PMC article.
242 results